199 related articles for article (PubMed ID: 23399352)
1. Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Gueli A; Gottardi D; Hu H; Ricca I; De Crescenzo A; Tarella C
Blood Transfus; 2013 Apr; 11(2):311-4. PubMed ID: 23399352
[No Abstract] [Full Text] [Related]
2. Therapy for chronic cold agglutinin disease: perspective for further improvements.
Berentsen S
Blood Transfus; 2013 Apr; 11(2):167-8. PubMed ID: 23399355
[No Abstract] [Full Text] [Related]
3. Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.
Burotto M; Stetler-Stevenson M; Arons E; Zhou H; Wilson W; Kreitman RJ
Clin Cancer Res; 2013 Nov; 19(22):6313-21. PubMed ID: 24097860
[TBL] [Abstract][Full Text] [Related]
4. HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine.
Tsutsumi Y; Ogasawara R; Miyashita N; Tanaka J; Asaka M; Imamura M
Int J Hematol; 2012 May; 95(5):588-91. PubMed ID: 22419099
[No Abstract] [Full Text] [Related]
5. [Alleviated anemia by bendamustine in cold agglutinin disease associated with small lymphocytic lymphoma].
Kuno M; Inoue A; Aimoto M; Nakao T; Kameda K; Yoshida M; Kanashima H; Hirai M; Yamane T
Rinsho Ketsueki; 2015 Feb; 56(2):204-9. PubMed ID: 25765801
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M
Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811
[No Abstract] [Full Text] [Related]
7. Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
Glaser M; Glaser A; Skalicky M
Wien Klin Wochenschr; 2011 Nov; 123(21-22):680-3. PubMed ID: 21947363
[TBL] [Abstract][Full Text] [Related]
8. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
[TBL] [Abstract][Full Text] [Related]
9. A case of autoimmune haemolytic anaemia achieving complete response with rituximab.
Dev M; Mushtaq N; Faisal A
J Pak Med Assoc; 2014 Jun; 64(6):700-2. PubMed ID: 25252495
[TBL] [Abstract][Full Text] [Related]
10. Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.
Bartel C; Obermüller N; Rummel MJ; Geiger H; Hauser IA
Clin Nephrol; 2008 Apr; 69(4):285-9. PubMed ID: 18397703
[TBL] [Abstract][Full Text] [Related]
11. Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: a serendipitous finding.
Shah BK; Hewett Y; Peterson A; Tretheway D
J Postgrad Med; 2014; 60(4):406-8. PubMed ID: 25370553
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome.
Seipelt G; Böhme A; Koschmieder S; Hoelzer D
Ann Hematol; 2001 Mar; 80(3):170-3. PubMed ID: 11320903
[TBL] [Abstract][Full Text] [Related]
13. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
Bauduer F
Br J Haematol; 2001 Mar; 112(4):1085-6. PubMed ID: 11324638
[No Abstract] [Full Text] [Related]
14. Cryoglobulins mimicking platelet recovery in a mantle cell lymphoma patient treated with chemoimmunotherapy.
Herishanu Y; Katz BZ
Blood; 2015 Feb; 125(6):1047. PubMed ID: 25802907
[No Abstract] [Full Text] [Related]
15. [Cold agglutinin disease - no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Rituximab in Refractory Cold Agglutinin Hemolytic Anemia in a Patient with Ataxia-Telangiectasia.
Abdulhag UN; Liebster D; Eisenstein EM; Berkun Y
Isr Med Assoc J; 2015 Jul; 17(7):455-6. PubMed ID: 26357726
[No Abstract] [Full Text] [Related]
17. Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia.
Seeliger S; Baumann M; Mohr M; Jürgens H; Frosch M; Vormoor J
Eur J Pediatr; 2001 Aug; 160(8):492-6. PubMed ID: 11548187
[TBL] [Abstract][Full Text] [Related]
18. [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
Sekkach Y; Hammi S; Elqatni M; Fatihi J; Elomri N; Mekouar F; Badaoui M; Jira M; Smaali J; El Khattabi A; Amezyane T; Abouzahir A; Ghafir D
Ann Pharm Fr; 2011 Jul; 69(4):205-8. PubMed ID: 21840439
[TBL] [Abstract][Full Text] [Related]
19. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases.
Eren R; Suyanı E
Turk J Haematol; 2018 Nov; 35(4):312-313. PubMed ID: 29983407
[No Abstract] [Full Text] [Related]
20. The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD).
Shoji J; Lew SQ
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
